Beam Therapeutics, Inc. (BEAM)
25.70
+1.10
(+4.47%)
USD |
NASDAQ |
Oct 09, 16:00
25.72
+0.02
(+0.08%)
After-Hours: 20:00
Beam Therapeutics Free Cash Flow : -372.77M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -372.77M |
| March 31, 2026 | -383.84M |
| December 31, 2025 | -360.05M |
| September 30, 2025 | -352.36M |
| June 30, 2025 | -355.57M |
| March 31, 2025 | -360.96M |
| December 31, 2024 | -356.19M |
| September 30, 2024 | -145.37M |
| June 30, 2024 | -153.40M |
| March 31, 2024 | -169.28M |
| December 31, 2023 | -182.93M |
| September 30, 2023 | -391.86M |
| June 30, 2023 | -380.41M |
| March 31, 2023 | -353.49M |
| Date | Value |
|---|---|
| December 31, 2022 | -26.42M |
| September 30, 2022 | 39.49M |
| June 30, 2022 | 123.00M |
| March 31, 2022 | 148.21M |
| December 31, 2021 | -113.08M |
| September 30, 2021 | -133.96M |
| June 30, 2021 | -155.22M |
| March 31, 2021 | -131.72M |
| December 31, 2020 | -112.10M |
| September 30, 2020 | -99.64M |
| June 30, 2020 | -94.01M |
| March 31, 2020 | -86.75M |
| December 31, 2019 | -84.52M |
| September 30, 2019 | -78.75M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Prime Medicine, Inc. | -156.85M |
| Intellia Therapeutics, Inc. | -348.69M |
| Twist Bioscience Corp. | -93.22M |
| Q32 Bio, Inc. | -19.83M |
| Sarepta Therapeutics, Inc. | 58.34M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -66.10M |
| Cash from Investing (Quarterly) | -9.875M |
| Cash from Financing (Quarterly) | 7.523M |
| Free Cash Flow Per Share (Quarterly) | -0.6567 |
| Free Cash Flow to Equity (Quarterly) | -65.05M |
| Free Cash Flow to Firm (Quarterly) | -68.51M |
| Free Cash Flow Yield | -13.98% |